139 related articles for article (PubMed ID: 37080399)
1. Effects and moderators of exercise medicine on cardiometabolic outcomes in men with prostate cancer previously or currently undergoing androgen deprivation therapy: An individual patient data meta-analysis.
Lopez P; Newton RU; Taaffe DR; Winters-Stone K; Buffart LM; Galvão DA
Crit Rev Oncol Hematol; 2023 Jun; 186():103995. PubMed ID: 37080399
[TBL] [Abstract][Full Text] [Related]
2. Moderators of resistance-based exercise programs' effect on sarcopenia-related measures in men with prostate cancer previously or currently undergoing androgen deprivation therapy: An individual patient data meta-analysis.
Lopez P; Newton RU; Taaffe DR; Winters-Stone K; Galvão DA; Buffart LM
J Geriatr Oncol; 2023 Jun; 14(5):101535. PubMed ID: 37229882
[TBL] [Abstract][Full Text] [Related]
3. The effect of exercise training on cardiometabolic health in men with prostate cancer receiving androgen deprivation therapy: a systematic review and meta-analysis.
Bigaran A; Zopf E; Gardner J; La Gerche A; Murphy DG; Howden EJ; Baker MK; Cormie P
Prostate Cancer Prostatic Dis; 2021 Mar; 24(1):35-48. PubMed ID: 32860010
[TBL] [Abstract][Full Text] [Related]
4. Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancer.
Taaffe DR; Buffart LM; Newton RU; Spry N; Denham J; Joseph D; Lamb D; Chambers SK; Galvão DA
BJU Int; 2018 Feb; 121(2):194-202. PubMed ID: 28872752
[TBL] [Abstract][Full Text] [Related]
5. Exercise Improves V˙O2max and Body Composition in Androgen Deprivation Therapy-treated Prostate Cancer Patients.
Wall BA; GALVãO DA; Fatehee N; Taaffe DR; Spry N; Joseph D; Hebert JJ; Newton RU
Med Sci Sports Exerc; 2017 Aug; 49(8):1503-1510. PubMed ID: 28319589
[TBL] [Abstract][Full Text] [Related]
6. A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer.
Newton RU; Taaffe DR; Spry N; Gardiner RA; Levin G; Wall B; Joseph D; Chambers SK; Galvão DA
BMC Cancer; 2009 Jun; 9():210. PubMed ID: 19563641
[TBL] [Abstract][Full Text] [Related]
7. Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial.
Cormie P; Galvão DA; Spry N; Joseph D; Chee R; Taaffe DR; Chambers SK; Newton RU
BJU Int; 2015 Feb; 115(2):256-66. PubMed ID: 24467669
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of multidisciplinary interventions in preventing metabolic syndrome and improving body composition in prostate cancer patients treated with androgen deprivation therapy: A systematic review and meta-analysis.
Yang U; Harikrishna A; Preda V; Chen J
Clin Nutr ESPEN; 2023 Dec; 58():27-49. PubMed ID: 38057016
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a multi-component exercise programme and nutritional supplementation on musculoskeletal health in men treated with androgen deprivation therapy for prostate cancer (IMPACT): study protocol of a randomised controlled trial.
Owen PJ; Daly RM; Livingston PM; Mundell NL; Dalla Via J; Millar JL; Fraser SF
Trials; 2017 Oct; 18(1):451. PubMed ID: 28974267
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy before or during androgen-deprivation therapy does not blunt the exercise-induced body composition protective effects in prostate cancer patients: A secondary analysis of two randomized controlled trials.
Newton RU; Mavropalias G; Fragala MS; Kraemer WJ; Häkkinen K; Taaffe DR; Spry N; Joseph D; Galvão DA
Exp Gerontol; 2021 Aug; 151():111427. PubMed ID: 34052346
[TBL] [Abstract][Full Text] [Related]
11. Lifestyle guidelines for managing adverse effects on bone health and body composition in men treated with androgen deprivation therapy for prostate cancer: an update.
Owen PJ; Daly RM; Livingston PM; Fraser SF
Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):137-145. PubMed ID: 28117386
[TBL] [Abstract][Full Text] [Related]
12. The effects of resistance exercise on body composition and physical function in prostate cancer patients undergoing androgen deprivation therapy: an update systematic review and meta-analysis.
Tian S; Ding M; Sun H
Aging Male; 2022 Dec; 25(1):281-292. PubMed ID: 36382930
[TBL] [Abstract][Full Text] [Related]
13. Age and androgen-deprivation therapy on exercise outcomes in men with prostate cancer.
Alberga AS; Segal RJ; Reid RD; Scott CG; Sigal RJ; Khandwala F; Jaffey J; Wells GA; Kenny GP
Support Care Cancer; 2012 May; 20(5):971-81. PubMed ID: 21538098
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of androgen deprivation therapy in prostate cancer patients.
Basaria S; Lieb J; Tang AM; DeWeese T; Carducci M; Eisenberger M; Dobs AS
Clin Endocrinol (Oxf); 2002 Jun; 56(6):779-86. PubMed ID: 12072048
[TBL] [Abstract][Full Text] [Related]
15. Immediate versus delayed exercise in men initiating androgen deprivation: effects on bone density and soft tissue composition.
Taaffe DR; Galvão DA; Spry N; Joseph D; Chambers SK; Gardiner RA; Hayne D; Cormie P; Shum DHK; Newton RU
BJU Int; 2019 Feb; 123(2):261-269. PubMed ID: 30239116
[TBL] [Abstract][Full Text] [Related]
16. Dietary interventions to improve body composition in men treated with androgen deprivation therapy for prostate cancer: a solution for the growing problem?
Umlauff L; Weber M; Freitag N; Fairman CM; Heidenreich A; Bloch W; Schumann M
Prostate Cancer Prostatic Dis; 2022 Feb; 25(2):149-158. PubMed ID: 34193946
[TBL] [Abstract][Full Text] [Related]
17. The clinical importance of quantifying body fat distribution during androgen deprivation therapy for prostate cancer.
Foulkes SJ; Daly RM; Fraser SF
Endocr Relat Cancer; 2017 Mar; 24(3):R35-R48. PubMed ID: 28062546
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular risk and bone loss in men undergoing androgen deprivation therapy for non-metastatic prostate cancer: implementation of standardized management guidelines.
Cheung AS; Pattison D; Bretherton I; Hoermann R; Lim Joon D; Ho E; Jenkins T; Hamilton EJ; Bate K; Chan I; Zajac JD; Grossmann M
Andrology; 2013 Jul; 1(4):583-9. PubMed ID: 23686896
[TBL] [Abstract][Full Text] [Related]
19. Body composition, fatigue and exercise in patients with prostate cancer undergoing androgen-deprivation therapy.
Newton RU; Jeffery E; Galvão DA; Peddle-McIntyre CJ; Spry N; Joseph D; Denham JW; Taaffe DR
BJU Int; 2018 Dec; 122(6):986-993. PubMed ID: 29750398
[TBL] [Abstract][Full Text] [Related]
20. The effects of exercise on body composition of prostate cancer patients receiving androgen deprivation therapy: An update systematic review and meta-analysis.
Shao W; Zhang H; Qi H; Zhang Y
PLoS One; 2022; 17(2):e0263918. PubMed ID: 35167609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
